Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-004930
Filing Date
2014-11-04
Accepted
2014-11-04 14:48:47
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20140930.htm 10-Q 722217
2 EX-10.2 srne-ex102_20140930384.htm EX-10.2 174696
3 EX-10.3 srne-ex103_20140930579.htm EX-10.3 133715
4 EX-31.1 srne-ex311_2014093025.htm EX-31.1 9549
5 EX-31.2 srne-ex312_2014093026.htm EX-31.2 9474
6 EX-32.1 srne-ex321_2014093027.htm EX-32.1 10886
  Complete submission text file 0001564590-14-004930.txt   4379150

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srne-20140930.xml EX-101.INS 448508
8 XBRL TAXONOMY EXTENSION SCHEMA srne-20140930.xsd EX-101.SCH 37255
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20140930_cal.xml EX-101.CAL 33535
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20140930_def.xml EX-101.DEF 122707
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20140930_lab.xml EX-101.LAB 307288
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20140930_pre.xml EX-101.PRE 226873
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 141192728
SIC: 8731 Services-Commercial Physical & Biological Research